naltrexone has been researched along with Myocardial Ischemia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 13 (68.42) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, W; Li, J; Wang, J; Zhang, Y | 1 |
| Ardell, JL; Ding, X; Hua, F; Sutherly, K; Williams, CA | 1 |
| Gu, C; Guo, H; Kaye, AD; Li, J; Pei, J; Sun, Z; Tong, G; Wang, Y; Wei, X; Yi, D; Yu, S; Zhang, Q | 1 |
| Chen, BP; Gao, YF; Mao, HJ; Wang, HP; Xia, Q | 1 |
| Chen, BP; Fan, FY; Mao, HJ; Xia, Q | 1 |
| Coles, JA; Iaizzo, PA; Sigg, DC | 1 |
| Cao, Z; Liu, L; Van Winkle, DM | 1 |
| Bespalova, ZhD; Lasukova, TV; Maslov, LN; Nagase, H; Oldgen, P; Rice, KK | 1 |
| Chang, WL; Lee, SS; Su, MJ | 1 |
| al'Absi, M; Beesley, L; Carroll, D; Edwards, L; France, CR; Martin, U; McIntyre, D; Ring, C | 1 |
| Ackermann, LW; Denning, GM; Dickson, EW; Hogrefe, CP; Ludwig, PS; Stoll, LL | 1 |
| Cobbe, SM; Hicks, MN; Oldroyd, KG | 1 |
| Eells, JT; Fryer, RM; Gross, GJ; Hsu, AK; Nagase, H | 1 |
| Li, HY; Wong, TM; Wu, S | 1 |
| Fryer, RM; Gross, GJ; Hsu, AK; Wang, Y | 1 |
| Cho, CH; Pei, JM; Wang, GY; Wang, WP; Wong, TM; Wu, S; Zhou, JJ | 1 |
| Kukreja, RC | 1 |
| Gross, GJ; Hsu, A; Moore, J; Patel, HH | 1 |
| Badhwar, V; Bolling, SF; Kilgore, K; Oeltgen, PR; Schwartz, CF; Su, TP | 1 |
1 trial(s) available for naltrexone and Myocardial Ischemia
| Article | Year |
|---|---|
Effects of opioid blockade with naltrexone and distraction on cold and ischemic pain in hypertension.
Topics: Adult; Attention; beta-Endorphin; Cold Temperature; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Touch | 2007 |
18 other study(ies) available for naltrexone and Myocardial Ischemia
| Article | Year |
|---|---|
[κ-opioid receptor agonist U50, 488H attenuates myocardial ischemia-reperfusionvia modulating Toll-like receptor 4/nuclear factor-κB signaling in rat].
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Coronary Artery Disease; Down-Regulation; Heart Conduction System; Myocardial Infarction; Myocardial Ischemia; Myocardium; Naltrexone; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
C2 spinal cord stimulation induces dynorphin release from rat T4 spinal cord: potential modulation of myocardial ischemia-sensitive neurons.
Topics: Animals; Brain Stem; Coronary Vessels; Dynorphins; Electric Stimulation; Excitatory Amino Acid Agonists; Ibotenic Acid; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Neural Pathways; Neurons; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spinal Cord; Substance P | 2008 |
U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Androstadienes; Animals; Apoptosis; Cardiotonic Agents; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Naltrexone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Wortmannin | 2011 |
[The study of effects and mechanism of U50, 488H on electrical coupling during ischemia in the perfused isolated rat heart].
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzophenanthridines; Connexin 43; Female; Heart; In Vitro Techniques; Myocardial Ischemia; Myocardium; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Signal Transduction | 2010 |
[Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antihypertensive Agents; Heart; In Vitro Techniques; Male; Myocardial Ischemia; Myocardium; Naltrexone; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2006 |
Role of kappa-opioid receptor activation in pharmacological preconditioning of swine.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Enkephalin, Leucine-2-Alanine; Hemodynamics; Ischemic Preconditioning, Myocardial; Morphine; Myocardial Infarction; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Narcotics; Pentazocine; Receptors, Opioid, kappa; Swine | 2003 |
Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels.
Topics: Adenosine Triphosphate; Animals; Benzamides; Cardiotonic Agents; Dose-Response Relationship, Drug; Dynorphins; Endorphins; Enkephalin, Methionine; Guanidines; Ischemic Preconditioning, Myocardial; Male; Mitochondria; Morphinans; Myocardial Ischemia; Myocytes, Cardiac; Naltrexone; Narcotic Antagonists; Potassium Channels; Rabbits; Receptors, Opioid, delta; Receptors, Opioid, kappa; Sarcolemma | 2003 |
Delta-opioid receptor antagonists exhibit properties of partial delta-receptor agonists in isolated perfused heart.
Topics: Animals; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Naltrexone; Oligopeptides; Perfusion; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta | 2004 |
Attenuation of post-ischemia reperfusion injury by thaliporphine and morphine in rat hearts.
Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Antioxidants; Aporphines; Creatine Kinase; Dose-Response Relationship, Drug; Heart; Male; Mitochondria; Morphine; Myocardial Ischemia; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Peroxidase; Plant Extracts; Potassium; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Risk; Time Factors | 2005 |
Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism.
Topics: Animals; Apoptosis; Disease Models, Animal; Gene Expression; Inflammation; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Opioid Peptides; Physical Exertion; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid; RNA, Messenger; Time Factors | 2008 |
Influence of hyperkalaemia and ischaemia on non-receptor-mediated cardiac electrophysiological effects of naloxone.
Topics: Action Potentials; Animals; Culture Techniques; Dose-Response Relationship, Drug; Electrophysiology; Heart Conduction System; Hyperkalemia; Morphine; Myocardial Ischemia; Naloxone; Naltrexone; Narcotic Antagonists; Rabbits; Refractory Period, Electrophysiological | 1993 |
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels.
Topics: Analgesics; Animals; Benzylidene Compounds; Blood Pressure; Coronary Circulation; Glyburide; Hypoglycemic Agents; Ischemic Preconditioning, Myocardial; Male; Mitochondria; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Potassium Channels; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta | 1999 |
Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Calcium; Cell Survival; Electrophysiology; Energy Metabolism; Heart Ventricles; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Membrane Potentials; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardial Ischemia; Myocardium; Naltrexone; Narcotic Antagonists; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Trypan Blue | 1999 |
Essential activation of PKC-delta in opioid-initiated cardioprotection.
Topics: Acetophenones; Alkaloids; Analgesics; Animals; Benzophenanthridines; Benzopyrans; Benzylidene Compounds; Enkephalin, Leucine-2-Alanine; Enzyme Activation; Enzyme Inhibitors; Heart Rate; Indoles; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Maleimides; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Naltrexone; Narcotic Antagonists; Phenanthridines; Protein Kinase C; Protein Kinase C-delta; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta | 2001 |
Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Heart; Heart Ventricles; HSP70 Heat-Shock Proteins; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Ischemia; Myocardium; Naltrexone; Narcotic Antagonists; Oligonucleotides, Antisense; Protective Agents; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2001 |
Essential role of oxygen radicals in delayed pharmacological preconditioning.
Topics: Animals; Antioxidants; Benzamides; Benzylidene Compounds; Dose-Response Relationship, Drug; Drug Therapy, Combination; Free Radicals; Humans; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Oxygen; Piperazines; Quinolines; Rats; Receptors, Opioid, delta; Tiopronin | 2001 |
BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation.
Topics: Animals; Antioxidants; Benzamides; Benzylidene Compounds; Dose-Response Relationship, Drug; Free Radicals; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardial Reperfusion; Naltrexone; Narcotic Antagonists; Piperazines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Tiopronin | 2001 |
Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists.
Topics: Analgesics, Opioid; Animals; Benzylidene Compounds; Cardiac Surgical Procedures; Coronary Circulation; Disease Models, Animal; Drug Evaluation, Preclinical; Enkephalin, D-Penicillamine (2,5)-; Heart Arrest, Induced; Hypothermia, Induced; Ischemic Preconditioning, Myocardial; Myocardial Ischemia; Naltrexone; Narcotic Antagonists; Organ Size; Oxygen Consumption; Rabbits; Receptors, Opioid, delta; Recovery of Function; Stroke Volume; Ventricular Pressure | 2001 |